Clinical significance of LOXL4 expression and features of LOXL4-associated protein–protein interaction network in esophageal squamous cell carcinoma
Authors:
- 21 March 2019
- journal article
- research article
- Published by Springer Nature in Amino Acids
- Vol. 51 (5) , 813-828
Abstract
Lysyl oxidase-like 4 (LOXL4), a member of the LOX family proteins, catalyzes oxidative deamination of lysine residues in collagen and elastin, which are responsible for maintaining extracellular matrix homeostasis. In this study, the mRNA expression of LOXL4 in seven esophageal squamous cell carcinoma (ESCC) cell lines and 15 ESCC pairs of clinical samples were examined. Furthermore, LOXL4 protein levels in the ESCC cell lines were determined using western blotting. With the use of immunofluorescence, LOXL4 was observed to be localized primarily in the cytoplasm, but was also present in the nucleus. In addition, the results indicated that the upregulated expression of LOXL4 was associated with poor survival in patients with ESCC even following curative resection (P = 0.010). Similar Kaplan–Meier estimator curves for proteins that interact with LOXL4, SUV39H1 (P = 0.014) and COL2A1 (P = 0.011), were plotted. The analyses based on the protein–protein interaction network depicted the expression of LOXL4 and its associated proteins as well as their functions, suggesting that LOXL4 and its associated proteins may serve a significant role in the development and progression of ESCC. In conclusion, the results of the present study suggest that LOXL4 is a potential biomarker for patients with ESCC, as well as SUV39H1 and COL2A1, and high expression levels of these genes are associated with poor prognosis in patients with ESCC.Keywords
Funding Information
- National Natural Science Foundation of China (81472613, 81360331)
- Natural Science Foundation of Guangdong Province (U1301227, U1601229)
- Guangdong Provincial Department of Science and Technology (2014A020212286)
- the Natural Science Foundation of Guangdong Province (2018A030313664)
This publication has 31 references indexed in Scilit:
- LOXL4 knockdown enhances tumor growth and lung metastasis through collagen-dependent extracellular matrix changes in triple-negative breast cancerOncotarget, 2017
- Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high‐grade serous ovarian cancerInternational Journal of Cancer, 2015
- miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the Oxidative Stress pathwayMolecular Cancer, 2014
- Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinomaInternational Journal of Cancer, 2014
- Histone Lysine Methyltransferase, Suppressor of Variegation 3-9 Homolog 1, Promotes Hepatocellular Carcinoma Progression and Is Negatively Regulated by MicroRNA-125bHepatology, 2012
- Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancerOncogene, 2012
- X-TileClinical Cancer Research, 2004
- Immunofluorescence2001
- CpG-rich islands and the function of DNA methylationNature, 1986
- The 5-methylcytosine content of DNA from human tumorsNucleic Acids Research, 1983